Skip to content

Study · Ex vivo tissue · 2011

4 results

Vasoactive intestinal polypeptide requires parallel changes in adenylate cyclase and phospholipase C to entrain circadian rhythms to a predictable phase.

An S, Irwin RP, Allen CN, Tsai C, Herzog ED

Journal of neurophysiology9 Mar 2011Cited by 66 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study4

4 results from studies that gave the peptide. No result from this study comes from people.

  1. 01LabEx vivo tissueMechanism

    In suprachiasmatic nucleus (SCN) preparations, single applications of VIP reset PER2 rhythms in a time- and dose-dependent manner that differed from light.

    In plain wordsIn lab tests on the brain's body clock, one VIP dose shifted the clock rhythm, and the shift depended on timing and dose.

    Outcome
    Not applicablePER2 rhythm reset by single VIP application
    Study

    n: not reported in source

    Outcome group
    Circadian rhythm · Nervous system and cognition
    Studied dose
    Dose not stated

    Source sentences

    Summary
    We found that single applications of VIP reset PER2 rhythms in a time- and dose-dependent manner that differed from light.
  2. 02LabEx vivo tissueMechanism

    In SCN preparations, blocking both adenylate cyclase and phospholipase C together was required to block VIP-induced phase shifts of SCN rhythms.

    In plain wordsIn lab tests on the brain's body clock, VIP shifts needed both of two signaling pathways to be blocked before they stopped.

    Outcome
    Not applicableSignaling pathways needed for VIP-induced phase shifts
    Study

    n: not reported in source

    Outcome group
    Circadian rhythm · Nervous system and cognition
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Unlike VIP-mediated signaling in other cell types, simultaneous antagonism of adenylate cyclase and phospholipase C activities was required to block the VIP-induced phase shifts of SCN rhythms.
  3. 03LabEx vivo tissueMechanism

    In SCN neurons, VIP rapidly increased intracellular cAMP in most neurons.

    In plain wordsIn lab tests on brain clock cells, VIP quickly raised cAMP, a cell signal, in most cells.

    Outcome
    IncreaseIntracellular cAMP in SCN neurons
    Study

    n: not reported in source

    Outcome group
    Circadian rhythm · Nervous system and cognition
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Consistent with this, VIP rapidly increased intracellular cAMP in most SCN neurons.
  4. 04LabEx vivo tissueMechanism

    In SCN preparations, daily VIP treatment entrained PER2 rhythms to a predicted phase angle within several days, depending on VIP concentration and the interval between applications.

    In plain wordsIn lab tests on the brain's body clock, daily VIP set the clock rhythm to a predicted phase within days, depending on dose and interval.

    Outcome
    Not applicableEntrainment of PER2 rhythms by daily VIP
    Study

    n: not reported in source

    Outcome group
    Circadian rhythm · Nervous system and cognition
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Critically, daily VIP treatment entrained PER2 rhythms to a predicted phase angle within several days, depending on the concentration of VIP and the interval between VIP applications.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    12 Oct 2026, 12:58 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 12:41 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.